495 related articles for article (PubMed ID: 31178819)
21. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
Front Neurol; 2020; 11():280. PubMed ID: 32431657
[No Abstract] [Full Text] [Related]
22. Clinical study of autonomic dysfunction in patients with autoimmune encephalitis.
He J; Lian Y
Immunobiology; 2023 Sep; 228(5):152711. PubMed ID: 37543010
[TBL] [Abstract][Full Text] [Related]
23. Antibody prevalence and immunotherapy response in Chinese patients with epilepsy and encephalopathy scores for patients with different neuronal surface antibodies.
Jia Y; Wang HF; Zhang MY; Wang YP
Chin Med J (Engl); 2021 Dec; 134(24):2985-2991. PubMed ID: 34882621
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.
Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK
Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625
[TBL] [Abstract][Full Text] [Related]
25. Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABA
Rada A; Hagemann A; Aaberg Poulsen C; Baumgartner T; Berki T; Blaabjerg M; Brenner J; Britton JW; Christiana A; Ciano-Petersen NL; Crijnen Y; Elišák M; Farina A; Friedman AR; Hayden Z; Hébert J; Holtkamp M; Hong Z; Honnorat J; Ilyas-Feldmann M; Irani SR; Kovac S; Marusic P; Muñiz-Castrillo S; Ramanathan S; Smith KM; Steriade C; Strippel C; Surges R; Titulaer MJ; Uy CE; de Vries JM; Bien CG; Specht U
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200225. PubMed ID: 38838283
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China.
Yao L; Yue W; Xunyi W; Jianhong W; Guoxing Z; Zhen H
J Clin Neurosci; 2019 Oct; 68():73-79. PubMed ID: 31331752
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort.
Li HY; Qiao S; Cui CS; Feng F; Liu XW; Yang XD
J Clin Neurosci; 2022 Jul; 101():137-143. PubMed ID: 35597061
[TBL] [Abstract][Full Text] [Related]
29. Clinical Study of Autonomic Dysfunction in Patients With Anti-NMDA Receptor Encephalitis.
Yan L; Zhang S; Huang X; Tang Y; Wu J
Front Neurol; 2021; 12():609750. PubMed ID: 33613429
[No Abstract] [Full Text] [Related]
30. Characteristics of Seizure and Antiepileptic Drug Utilization in Outpatients With Autoimmune Encephalitis.
Huang Q; Ma M; Wei X; Liao Y; Qi H; Wu Y; Wu Y
Front Neurol; 2018; 9():1136. PubMed ID: 30671012
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA
de Bruijn MAAM; van Sonderen A; van Coevorden-Hameete MH; Bastiaansen AEM; Schreurs MWJ; Rouhl RPW; van Donselaar CA; Majoie MHJM; Neuteboom RF; Sillevis Smitt PAE; Thijs RD; Titulaer MJ
Neurology; 2019 May; 92(19):e2185-e2196. PubMed ID: 30979857
[TBL] [Abstract][Full Text] [Related]
32. Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.
Zhang Y; Liu G; Jiang M; Chen W; He Y; Su Y
Neurocrit Care; 2018 Oct; 29(2):264-272. PubMed ID: 29651625
[TBL] [Abstract][Full Text] [Related]
33. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
Front Immunol; 2021; 12():719432. PubMed ID: 34975832
[TBL] [Abstract][Full Text] [Related]
34. Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers.
Bien CG; Rohleder C; Mueller JK; Bien CI; Koethe D; Leweke FM
Front Psychiatry; 2021; 12():654602. PubMed ID: 33841216
[TBL] [Abstract][Full Text] [Related]
35. Temporal rank of clinical characteristics and prognosis of anti-N-methyl-d-aspartate receptor encephalitis.
Yang R; Ge F; Jiang J; Wang Y; Wan M; Zhang W
Brain Behav; 2021 Aug; 11(8):e2277. PubMed ID: 34232562
[TBL] [Abstract][Full Text] [Related]
36. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
[TBL] [Abstract][Full Text] [Related]
37. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
Wang Y; Zhang W; Yin J; Lu Q; Yin F; He F; Peng J
J Neuroimmunol; 2017 Nov; 312():59-65. PubMed ID: 28935354
[TBL] [Abstract][Full Text] [Related]
38. Improving the antibody-based evaluation of autoimmune encephalitis.
McCracken L; Zhang J; Greene M; Crivaro A; Gonzalez J; Kamoun M; Lancaster E
Neurol Neuroimmunol Neuroinflamm; 2017 Nov; 4(6):e404. PubMed ID: 29075658
[TBL] [Abstract][Full Text] [Related]
39. Pediatric Autoimmune Encephalitis: Case Series From Two Chinese Tertiary Pediatric Neurology Centers.
Zhang J; Ji T; Chen Q; Jiang Y; Cheng H; Zheng P; Ma W; Lei T; Zhang Y; Jin Y; Wei C; Wu Y; Chang X; Bao X; Zhang Y; Xiong H; Ji X; Feng S; Ren H; Yang J; Jiang Y
Front Neurol; 2019; 10():906. PubMed ID: 31507515
[No Abstract] [Full Text] [Related]
40. [Disease Characteristics, Treatment, and Prognosis of Chinese Patients with Autoimmune Encephalitis: A Retrospective Study].
Yang RN; Ge FF; Jiang JW; Wang Y; Zhang W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):142-148. PubMed ID: 35048615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
